Treatment of recurrent erythema nodosum leprosum with infliximab.
Faber
William R
WR
Jensema
Annigje J
AJ
Goldschmidt
Wouter F M
WF
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004893:Erythema Nodosum / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D000069285:Infliximab; D015440:Leprosy, Lepromatous / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab